The relative mRNA expression levels of CDK4, CDK6, CCND1, p16INK4a, p15INK4b, and RB were assessed in 44 prostate cancer tissues and 31 BPH tissues using qRT-PCR. Here, CDKN2A is linked to benign prostatic hyperplasia.